Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Important to remember that EPGL never said it would reach .10 by that date. That was merely posters on this board giving their opinions. It's impossible to predict any stock. If it were possible, we would all be mega millionaires. Important thing is they are doing all the right things to get this over .10 in the near future and I believe we will reach that pps soon.
Just posted it.
Love how EPGL always seems to go above and beyond. Q & A was to last until 6:30. They held it over an additional 20 minutes.
Q & A Session in Full Context
Welcome to tonight's EPGL Investor Q&A. We will go until 6:30 EST tonight. Ask your questions at investors@epglmed.com if you have not yet.
Eric asks about the DTC issue. Eric, we have been told that the restrictions will be lifted this week. Stay tuned. We are relying on DTC to do this in a timely manner as all documents have been filed according to their requests. When a company has been non-reporting for over 2 years, in addition to the toxic financing it was under, the DTC made the restrictions. We are now clearing all that up. This will be a significant improvement in EPGL's liquidity, meaning that all brokers will allow purchasing of EPGL stock, when that has not been the case. EPGL management believes this issue could increase volume by on average 50% above current levels. We have had numerous people contact us, wanting to buy EPGL shares, but cannot. So, the takeaway is, stay tuned. It will happen very soon.
Charlie asks about OTCQX timing. Charlie, management is confident that EPGL will reach 10 cents in coming weeks, soon enough that the required time frames by OTC will be met. Managment believes that coming events and news will justify much higher share prices.. or should justify higher share prices. We cannot fully predict market conditions and unknown factors, but with new revenues on the way, new device progress and new benchmarks being reached, we are confident we will move up OTC tiers. Shareholders will benefit greatly if our plans are fully executed. We plan to fully execute our plans.
Roger asks about Pricewaterhouse shares. Roger, PWC is holding their shares firmly presently. They have not offered to sell them and we have not attempted to purchase them as yet. EPGL does have first right of refusal however.
Brent asks about MPDD manufacturing. Brent, we can say that devices will be existing to fill orders. Yes, we have orders to fill and many physicians are awaiting the availability of the devices. The feedback we are receiving on the MPDD in the field is absolutely solid and completely backs the original research done at NYU. This device offers all physicians a tool they do not presently have. Doctors practice "defensive medicine" today due to insurance and liability risks. One of the reasons EPGL is so enthusiastic about MPDD, is that is has the potential to become a required device by most insurance companies, Medicare and Medicaid. Because the device can save costs and more accurately diagnose what kind of condition the patient has physicians of all kinds will feel the need to have performed an evaluation with MPDD to avoid patient liability and to satisfy insurance requirements. EPGL managment believes that is the direction MPDD is headed and for that matter, all of the new devices slated in R&D.
Stephen asks about name change and ticker. Stephen, no we will never change the ticker symbol. It will remain EPGL and the name will change at some point this year. Please stay tuned on this front.
Binayak, PWC is a great partner in the restructuring and a major shareholder in EPGL. They are committed to significant growth of EPGL and the market capitalization before they will consider selling their holdings. Neither, they, nor Mr. Hayes will consider selling shares on a retail level such as was the case with NIR funds. The Company management has stated on several occasions now, that they are committed to shareholder equity growth and will not consider any transactions now or in the future that would be detrimental to EPGL shareholders. PWC and Hayes' interests are fully aligned with those of other holders of common shares.
Jeremy asks about moving up the release date. Jeremy, the release date was moved up because management felt it was imperative to do so, based on the demand the Company is beginning to see increase for the device and the follow up MPTT. In addition, management has received several heartfelt letters and emails from people suffering from back pain, migraines, neck pain and other forms of pain, which have them literally debilitated. Since the device is doing well in the initial doctors hands, that was the signal for us that justified moving up the release date. That plus some other upcoming events which will be made public in coming weeks, which affect the sales potential greatly for the MPDD and all EPGL devices forthcoming.
Anthony asks about other devices releases in 2013. Anthony, yes. The MPTT will be released by end of year if all goes to plan. Possibly two other devices. We refer you to our last Shareholder update PR which listed some of the devices under development. Anthony, As we are still at the beginning stages here, we will have announcements of Board of Director members and other executives coming..Stay tuned on that front. Shareholders should be encouraged to know that presently EPGL possesses technology which no other Medical Device companies presently have..Unique know-how and design of Biomems oriented devices is the key to EPGL success going forward.
We would like to thank all EPGL shareholders for being part of the newly restructured company. The uniqueness of EPGL is that it has many shareholders who originally invested in the Company long ago for very good reasons. The new EPGL will continue to do good work which will be beneficial to societies around the globe. This strong base of long-term shareholders, makes EPGL very unique.
Thank you for participating in tonight's QA session. EPGL Team will keep you updated on developments as they come and please watch for further updates and events in March, including the MPDD release, a Shareholder update on March 29 and our second Live Conference call to be held March 29, 2013 at 6:00PM EST. Also, stay tuned to Twitter daily as the Company will have regular updates here too.
I agree. Was just addressing those that always want to know whys and how's the day after q&a.
Don't forget about the Twitter Q&A at 6:00 PM ET. I've already submitted my questions. Don't wait until tomorrow and start asking questions that you could get the answers to tonight. If you have legitimate questions, send it in now to investors@epglmed.com
Yes, as does TDA who want allow you to open new orders. Don't like IH's policy on that.
Full tweet - 37 minutes ago
EPGL Alert: All indications are DTC restriction will be lifted shortly, increasing the number of brokers who can trade EPGL stock. EPGL anticipates this could happen as early as this week and will keep shareholders posted on this development. - EPGL TEAM
Very True!
Interesting. Their previous PR came through ok and it shows up everywhere else.
I say post anywhere we can. The more eyes the better and the quicker we get uplisted. It won't take long with a little volume to completely absorb this entire float.
No idea. Viking has already sent them a message this morning.
Key will be removing the DTC issue and breaking .10. After breaking .10 and uplisting, we'll leave all the flippers behind and big eyes and wallets will be all over EPGL. This level of pink has been littered with so many scams in the past few years, it's hard for the casual observer to have faith in what has been taking place here over the last year. Anyone who takes the time to truly do their DD, takes a position. I've been adding along and have finally reached my goal of 500K shares. I'm all set for when we hit $3+.
News still not showing on IHUB.
Got mine filled. Now lets keep above .04 for the day!
Trying to slap the ask for 22K More.
Keep hearing this theme of EPGL PR not telling us X and Y. I for one am grateful that I'm not hearing fake predictions from the company in terms of false order numbers, etc. We're getting the facts as they come in and that is priceless in pinkyville. I don't want to hear fluff, just facts. If we were getting unverifiable fluff, we would still be in the .00's with wild bounces and swings everyday.
I just tried a small order via TDA and they are still not allowing new orders. This is huge. When the DTC Rest. are removed, I really think that will be huge. If you're looking at investing a large sum and you hold a TDA account, it would certainly give you some pause when you place an order and you get this message, Order cannot be processed due to a DTC chill restricting the ability to transfer a security and settle the trade. If I'm a new investor, I wouldn't open a new broker account. I would wait until TDA started allowing trading. We need that sense of comfort for new investors imo.
Yes, no hurry here. End game in site. Any cheapies that come up will be gobbled up fast. I would like to add another 20k when my funds come available and would be delighted if I can pick up some more in the 3's. I just hope I can do so before the DTC issue is resolved. I think that alone will be a major catalyst for us and that is set to happen at any moment now.
I know. Very disappointing. Do you know what the procedure is for them to post the news? Is it automatic, or does a mod have to notify IHUB? I think Viking has messaged them already.
Insider? What are you talking about? Read my posts from years ago. I've been in EPGL since it was a digital magazine and thought I lost all of my money. Once this became something real and I actually had a gain in my account from EPGL, I loaded up more between .033 and .0385.
Here's your see. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/ucm318431.htm
It's up to you as to believing or not. This doesn't look like a fairytale to me..
Then stop thinking. It's not working out very well for you. I've been buying all along and loaded up 280,000 more shares on the last dip in the 3's and have my trade confirmations to prove it. Who are you to suggest that I wouldn't buy? That's out of line. EPGL has followed through with absolutely everything they have promised thus far. There are a lot of factors as to why significant volume isn't here yet, most importantly IMO is the DTC issue. Once that's lifted, I think we'll see a lot more confidence and interest flowing in. Their life jacket is their business model which has been fantastic.
I'm there with you!
Are you kidding???? If this fell back in to the 3's, I'd be scrambling to load up all I could.
Fox News is great. Millions watch Fox & many depend on Fox for investment advice, etc. Great exposure.
This was my favorite part of the PR just behind the advanced release date. The NASDAQ requirements are:
The regular bid price at time of listing must be $4, and there must be at least three market makers for the stock. However, a company may qualify under a closing price alternative of $3 or $2 if the company meets varying reequirements.
Listing Standard No. 1
The company must have aggregate pre-tax earnings in the prior three years of at least $11 million, in the prior two years at least $2.2 million, and no one year in the prior three years can have a net loss.
Listing Standard No. 2
The company must have a minimum aggregate cash flow of at least $27.5 million for the past three fiscal years, with no negative cash flow in any of those three years. In addition, its average market capitalization over the prior 12 months must be at least $550 million, and revenues in the previous fiscal year must be $110 million, minimum.
Listing Standard No. 3
Companies can be removed from the cash flow requirement of Standard No. 2 if the average market capitalization over the past 12 months is at least $850 million, and revenues over the prior fiscal year are at least $90 million.
A company has three ways to get listed on the Nasdaq, depending on the underlying fundamentals of the company. If a company does not meet certain criteria, such as the operating income minimum, it has to make it up with larger minimum amounts in another area like revenue. This helps to improve the quality of companies listed on the exchange.
Is it Monday morning yet?
TWEET
A portion of this mornings tweet was posted, but a very important part in my opinion was omitted. Here is the complete tweet.
EPGL Team is now receiving inquiries from patients who want to know where they can be treated with MPDD.... Developing
EPGL Investor Update Monday Morning Pre-Market to Announce MPDD Wide Release Date and All Other Developments of Interest to Shareholders. EPGL National PR Pre-Market Monday February 25, 2013. Followed by Twitter Q&A Session at 6:00PM EST. HAVE A NICE WEEKEND
They have corrected the date on the top of the physician review.
http://www.epglmed.com/EPGL_Medical_Sciences/Home_files/MPDD%20Review%201.pdf
Gotta love that wide B/A spread. Supports a little weak now during the ole lunchtime lull.
Maybe not this time. That 50k order just moved NITE up this time. Maybe they're ready to let it roll.
Yea, I think the s.o.n. occurred yesterday, and it was not much to speak of. I think Monday is going to be a lot of fun!
I'm guessing NITE's 50k at 46 is fake too. It took a 300k buy to finally knock him off of his 10K
Another 10K and NITE won't budge. What gives?
Love how NITE has 10K of .045 on ask and we've had 82K go through and he keeps that 10K up. Time to move up to .047
They've already addressed this. I think we may see an update on the in the PR Monday. Could happen at any minute.
Bid building too.
I'm sure the 12 was just a mistake. I'm still writing 2012 on my contracts. You would think by almost March I would be used to 13, but still have trouble with it, lol.